Literature DB >> 8895505

Flavonoids activate wild-type p53.

B Plaumann1, M Fritsche, H Rimpler, G Brandner, R D Hess.   

Abstract

Flavonoids are diphenyl propanoids widely distributed in edible plants. They play a dual role in mutagenesis and carcinogenesis. Some of them act as anticarcinogens or inhibit the growth of tumour cells, whereas others act as cocarcinogens, are mutagenic or able to induce DNA damage. To further elucidate this dual role, we investigated the influence of apigenin, luteolin and quercetin on the tumour suppressor protein p53, regarding p53 accumulation, cell cycle arrest, apoptosis, and biological activity. We found that incubation of the non-tumour cell line C3H10T1/2CL8 with these flavonoids resulted in induction of p53 accumulation and apoptosis. Apoptosis occurred out of the G2/M phase of the cell cycle. The G2/M arrest seems to be p53-dependent as it did not occur in p53 knockout fibroblasts which further supports the recent finding that p53 is involved in the G2/M checkpoint control. Differences between the flavonoids tested concerned p53 accumulation kinetics as well as the biological activity of accumulated p53 and might be due to different modes of flavonoid action. These data suggest that both aspects of flavonoid effects, i.e. inhibition of tumour growth through cell cycle arrest and induction of apoptosis, are functionally related to p53.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895505

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  36 in total

Review 1.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

2.  Upstream regulatory elements in chick heme oxygenase-1 promoter: a study in primary cultures of chick embryo liver cells.

Authors:  T H Lu; Y Shan; J Pepe; R W Lambrecht; H L Bonkovsky
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

3.  IL-8-induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3).

Authors:  Karen M Henkels; Kathleen Frondorf; M Elba Gonzalez-Mejia; Andrea L Doseff; Julian Gomez-Cambronero
Journal:  FEBS Lett       Date:  2010-11-21       Impact factor: 4.124

4.  Induction of apoptosis in human lymphoblastoid cells by kaempferol 3-O-β-isorhamninoside and rhamnocitrin 3-O-β-isorhamninoside from Rhamnus alaternus L. (Rhamnaceae).

Authors:  W Bhouri; I Bouhlel; J Boubaker; S Kilani; K Ghedira; L Chekir Ghedira
Journal:  Cell Prolif       Date:  2011-06       Impact factor: 6.831

5.  Preclinical colorectal cancer chemopreventive efficacy and p53-modulating activity of 3',4',5'-trimethoxyflavonol, a quercetin analogue.

Authors:  Lynne M Howells; Robert G Britton; Marco Mazzoletti; Peter Greaves; Massimo Broggini; Karen Brown; William P Steward; Andreas J Gescher; Stewart Sale
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-13

6.  Serum deprivation confers the MDA-MB-231 breast cancer line with an EGFR/JAK3/PLD2 system that maximizes cancer cell invasion.

Authors:  Qing Ye; Samuel Kantonen; Julian Gomez-Cambronero
Journal:  J Mol Biol       Date:  2012-12-10       Impact factor: 5.469

Review 7.  Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.

Authors:  Xin Tong; Jill C Pelling
Journal:  Anticancer Agents Med Chem       Date:  2013-09       Impact factor: 2.505

8.  Plant flavone apigenin: An emerging anticancer agent.

Authors:  Eswar Shankar; Aditi Goel; Karishma Gupta; Sanjay Gupta
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

9.  Cytotoxicity and genotoxicity of zingiberene on different neuron cell lines in vitro.

Authors:  Basak Togar; Hasan Turkez; Abdulgani Tatar; Ahmet Hacimuftuoglu; Fatime Geyikoglu
Journal:  Cytotechnology       Date:  2014-05-07       Impact factor: 2.058

Review 10.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.